FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Morton Grove Pharmaceuticals Amoxicillin and Clavulanate Potassium for Recall

Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62

Morton Grove Pharmaceuticals, Inc. · Morton Grove, IL

Risk level
Class II
Reported by FDA
Sep 6, 2017
Recall ID
D-1125-2017
Check your lot numberHow we source this data

Summary

Morton Grove Pharmaceuticals recalled Amoxicillin and Clavulanate Potassium for starting Aug 10, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1125-2017 on Sep 6, 2017. Reason: Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product.

Product description

Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62.5 mg per 5 mL, 100 mL (when reconstituted) bottle, Rx Only, Manufactured By: Cipla Ltd. at Medispray Laboratories Pvt. Ltd., Kundaim Goa, India; Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054, NDC 60432-065-00.

Lot numbers, UPCs & expiration codes

Batch #: KH60276, Exp 10/18

Where it was sold

Nationwide in the USA and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1125-2017
Classification
Class II
Status
Terminated
Recall initiated
Aug 10, 2017
FDA report date
Sep 6, 2017
Quantity
7332 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Morton Grove Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1125-2017, exactly as published.

Show all FDA fields
City
Morton Grove
State
IL
Status
Terminated
Country
United States
Event ID
77933
Address
6451 Main St
Code information
Batch #: KH60276, Exp 10/18
Postal code
60053-2633
Report date
Sep 6, 2017
Product type
Drugs
Recall number
D-1125-2017
Classification
Class II
Recalling firm
Morton Grove Pharmaceuticals, Inc.
Product quantity
7332 bottles
Termination date
Sep 13, 2018
Reason for recall
Presence of Foreign Substance: customer complaint of blue foreign material identified as a portion of a nitrile glove was discovered in product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Amoxicillin and Clavulanate Potassium for Oral Suspension, USP, 250/62.5 mg per 5 mL, 100 mL (when reconstituted) bottle, Rx Only, Manufactured By: Cipla Ltd. at Medispray Laboratories Pvt. Ltd., Kundaim Goa, India; Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054, NDC 60432-065-00.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Recall initiation date
Aug 10, 2017
Initial firm notification
Letter
Center classification date
Aug 29, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1125-2017, published Sep 6, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls